| R21122012 |
AGI-001;Espindolol |
Espindolol is a β-adrenoceptor antagonist potentially for the treatment of cache
|
| R21122013 |
PDZ1i |
PDZ1i (113B7) is a specific inhibitor of MDA-9/Syntenin activity, which inhibits
|
| R21122014 |
ARN-21934 |
Arn-21934 is a novel and highly selective human topoisomerase IIα inhibitor with
|
| R21122015 |
SID 26681509 |
SID 26681509 is a potent, reversible, competitive and selective inhibitor of hum
|
| R21122016 |
FFN246 |
FFN246 is a novel fluorescent substrate of 5-hydroxytryptamine transporter and v
|
| R21122017 |
superstat |
Novel selective histone deacetylase 6 (HDAC6) inhibitors enhance immunotherapy i
|
| R21122018 |
VU-29 |
Vu-29 is a positive allosteric regulator of metabolic glutamate 5 (mGlu5) recept
|
| R21122019 |
Phevamine A |
Novel plant immune response inhibitors.
|
| R21122020 |
ML202 |
|
| R21122021 |
Adaphostin |
Adaphostin is a novel activator of Fas-mediated death pathway in Bcr/Abl-positiv
|
| R21122022 |
BRD0418 |
Novel upregulation factors expressed by TRIB1 lead to reprogramming of hepatic l
|
| R21122023 |
BTA-EG4 hydrate |
|
| R21122024 |
BRD-K98645985 |
Brd-k98645985 is a class of 12 yuan macrocyclic lactam and is also an inhibitor
|
| R21122025 |
GSK778 |
GSK778 (iBET-BD1) is a potent and selective BD1 bromodomain inhibitor of the BET
|
| R21122026 |
Synucleozid |
Synucleozid (NSC 377363) is a potent inhibitor of the SNCA mRNA that encodes α-s
|
| R21122027 |
APS6-45 |
APS6-45 is an orally active tumor-calibrated inhibitor (TCI). APS6-45 inhibits R
|
| R21122028 |
SW-100 |
SW-100, a selective histone deacetylase 6 (HDAC6) inhibitor with an IC50 of 2.3
|
| R21122029 |
SB-224289 hydrochloride |
SB-224289 hydrochloride is a selective 5-HT1B receptor antagonist, with anxiolyt
|
| R21122030 |
SKI-178 |
SKI-178 is a potent sphingosine kinase-1 (SphK1) and SphK2 inhibitor. SKI-178 is
|
| R21122031 |
Azo-Resveratrol |
|
| R21122032 |
Dersimelagon |
Dersimelagon is a melanocortin receptor agonist.
|
| R21122033 |
Tradipitant |
Tradipitant (VLY-686) is a neurokinin-1 (NK-1) antagonist.
|
| R21122034 |
GSK-3;CDK5;CDK2-IN-1 |
GSK-3/CDK5/CDK2-IN-1, an imidazole derivative, is an inhibitor of cdk5, cdk2, an
|
| R21122035 |
VK-28 |
|
| R21122036 |
BIBO3304 TFA |
BIBO3304 TFA is a potent, orally active, and selective neuropeptide Y (NPY) Y1 r
|